Osteoarthritis Market Report 2026
Download Free Sample Buy Now
Osteoarthritis Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Osteoarthritis Market Report 2026

Global Outlook – By Treatment (Medication, Surgery, Therapy), By Diagnosis (Imaging, Joint Fluid Analysis), By Route Of Administration (Parenteral Route, Topical Route, Oral Route), By Disease Type (Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis), By End-User (Hospitals, Medical Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Osteoarthritis Market Overview

• Osteoarthritis market size has reached to $7.49 billion in 2025

• Expected to grow to $11.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%

• Growth Driver: Rising Obesity-Related Disorders Fuel Growth In The Osteoarthritis Market

• Market Trend: Partnership Approaches And Advanced Treatments Transform The Osteoarthritis Market

• North America was the largest region in 2025.

What Is Covered Under Osteoarthritis Market?

Osteoarthritis is a form of arthritis that solely affects the joints, typically the hands, knees, hips, neck and lower back. It develops when the cartilage that covers and shields the ends of the bones gradually erodes. Osteoarthritis treatment aims to reduce pain, improve joint function and slow down the progression of the disease.

The main treatments for osteoarthritis are medication, surgery and therapy. Medication refers to the use of medications or medicine to treat or relieve a certain condition or illness. Osteoarthritis pain can be reduced with the use of medications including nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen and opioids. The diagnosis includes imaging and joint fluid analysis. The medication can be administered through the parenteral route, topical route and oral routes for the treatment of knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis and hand osteoarthritis. The end-users are hospitals and medical institutes.

Osteoarthritis Market Global Report 2026 Market Report bar graph

What Is The Osteoarthritis Market Size and Share 2026?

The osteoarthritis market size has grown strongly in recent years. It will grow from $7.49 billion in 2025 to $8.16 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis globally, limited availability of advanced joint therapies in early periods, increasing aging population with joint degeneration, early adoption of conventional medications and surgeries, growing awareness of joint health and pain management.

What Is The Osteoarthritis Market Growth Forecast?

The osteoarthritis market size is expected to see strong growth in the next few years. It will grow to $11.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to rising adoption of minimally invasive and robotic-assisted surgeries, increasing use of biologics and dmoads, expanding healthcare infrastructure for joint care, growing adoption of digital diagnostics and ai-based monitoring, increasing patient awareness of lifestyle and weight management programs. Major trends in the forecast period include rising adoption of minimally invasive joint replacement surgeries, increasing use of biologic therapies and hyaluronic acid injections, growing integration of digital imaging and ai-based diagnostics, rising focus on personalized osteoarthritis management plans, increasing investment in physical therapy and rehabilitation programs.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Osteoarthritis Market Segmentation

1) By Treatment: Medication, Surgery, Therapy

2) By Diagnosis: Imaging, Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

5) By End-User: Hospitals, Medical Institutes

Subsegments:

1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

What Is The Driver Of The Osteoarthritis Market?

The increasing obesity-related disorders are expected to boost the growth of the osteoarthritis market going forward. Obesity-related problems refer to a range of health issues that can arise from excessive body fat. It is caused by consuming more calories than the body burns through physical activity and exercise, eating large amounts of processed or fast food, and drinking too much alcohol. Obesity can induce osteoarthritis by putting strain on joints, producing inflammation, and altering hormones, thus increasing the load on the joints. For instance, in September 2024, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, the number of states with adult obesity prevalence of 35% or higher rose from 22 states in 2022 to 23 states in 2023. Therefore, the increasing obesity-related disorders are driving the growth of the osteoarthritis industry.

Key Players In The Global Osteoarthritis Market

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Global Osteoarthritis Market Trends and Insights

Major companies operating in the osteoarthritis market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in July 2024, LG Chem, a South Korea-based pharmaceutical company, entered the Chinese market through a partnership with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and production company, to launch Synovian injection for osteoarthritis and provide similar therapeutic effects to traditional multi-injection formulations but with just one administration. Unique features of Synovian include its high molecular weight (10 million Dalton) hyaluronic acid, which enhances viscoelasticity and joint function, and its ability to significantly reduce knee pain based on clinical phase 3 trial results. This advancement positions Synovian as an effective option for patients seeking convenient relief from osteoarthritis symptoms.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Osteoarthritis Market?

In November 2023, Smith & Nephew, a UK-based medical-technology company specializing in orthopaedics, sports medicine, arthroscopic technologies, and wound care, acquired CartiHeal for US$180 million upfront. With this acquisition, Smith & Nephew aims to expand its osteoarthritis and joint-repair portfolio through the integration of a biologic cartilage-regeneration technology, strengthening its long-term leadership in sports medicine. CartiHeal is an Israel-based developer of the Agili-C scaffold, a porous, biocompatible implant designed for one-step cartilage and subchondral bone repair in knees with osteochondral lesions, including those in mild to moderate osteoarthritis.

Regional Outlook

North America was the largest region in the osteoarthritis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Osteoarthritis Market?

The osteoarthritis market consists of revenues earned by entities by providing services such as physical therapy, occupational therapy, weight management, exercise and physical activity, patient education, self-management programs and joint protection techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The osteoarthritis market also includes sales of viscosupplementation agents, analgesics, corticosteroids and assistive devices such as braces, canes, or shoe inserts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Osteoarthritis Market Report 2026?

The osteoarthritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the osteoarthritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Osteoarthritis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $8.16 billion
Revenue Forecast In 2035 $11.92 billion
Growth Rate CAGR of 8.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Diagnosis, Route Of Administration, Disease Type, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Osteoarthritis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Osteoarthritis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Osteoarthritis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Osteoarthritis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Rising Adoption Of Minimally Invasive Joint Replacement Surgeries

4.2.2 Increasing Use Of Biologic Therapies And Hyaluronic Acid Injections

4.2.3 Growing Integration Of Digital Imaging And Ai-Based Diagnostics

4.2.4 Rising Focus On Personalized Osteoarthritis Management Plans

4.2.5 Increasing Investment In Physical Therapy And Rehabilitation Programs

5. Osteoarthritis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Medical Institutes

5.3 Orthopedic Clinics

5.4 Rehabilitation Centers

5.5 Other End Users

6. Osteoarthritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Osteoarthritis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Osteoarthritis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Osteoarthritis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Osteoarthritis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Osteoarthritis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Osteoarthritis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Osteoarthritis Market Segmentation

9.1. Global Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medication, Surgery, Therapy

9.2. Global Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging, Joint Fluid Analysis

9.3. Global Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parenteral Route, Topical Route, Oral Route

9.4. Global Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

9.5. Global Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Medical Institutes

9.6. Global Osteoarthritis Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

9.7. Global Osteoarthritis Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

9.8. Global Osteoarthritis Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

10. Osteoarthritis Market Regional And Country Analysis

10.1. Global Osteoarthritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Osteoarthritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Osteoarthritis Market

11.1. Asia-Pacific Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Osteoarthritis Market

12.1. China Osteoarthritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Osteoarthritis Market

13.1. India Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Osteoarthritis Market

14.1. Japan Osteoarthritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Osteoarthritis Market

15.1. Australia Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Osteoarthritis Market

16.1. Indonesia Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Osteoarthritis Market

17.1. South Korea Osteoarthritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Osteoarthritis Market

18.1. Taiwan Osteoarthritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Osteoarthritis Market

19.1. South East Asia Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Osteoarthritis Market

20.1. Western Europe Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Osteoarthritis Market

21.1. UK Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Osteoarthritis Market

22.1. Germany Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Osteoarthritis Market

23.1. France Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Osteoarthritis Market

24.1. Italy Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Osteoarthritis Market

25.1. Spain Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Osteoarthritis Market

26.1. Eastern Europe Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Osteoarthritis Market

27.1. Russia Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Osteoarthritis Market

28.1. North America Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Osteoarthritis Market

29.1. USA Osteoarthritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Osteoarthritis Market

30.1. Canada Osteoarthritis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Osteoarthritis Market

31.1. South America Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Osteoarthritis Market

32.1. Brazil Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Osteoarthritis Market

33.1. Middle East Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Osteoarthritis Market

34.1. Africa Osteoarthritis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Osteoarthritis Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Osteoarthritis Market Regulatory and Investment Landscape

36. Osteoarthritis Market Competitive Landscape And Company Profiles

36.1. Osteoarthritis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Osteoarthritis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Osteoarthritis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck Sharp & Dohme Corp. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Osteoarthritis Market Other Major And Innovative Companies

Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc.

38. Global Osteoarthritis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Osteoarthritis Market

40. Osteoarthritis Market High Potential Countries, Segments and Strategies

40.1 Osteoarthritis Market In 2030 - Countries Offering Most New Opportunities

40.2 Osteoarthritis Market In 2030 - Segments Offering Most New Opportunities

40.3 Osteoarthritis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Osteoarthritis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Osteoarthritis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Osteoarthritis Market, Supply Chain Analysis
  • Table 4: Global Osteoarthritis Market, Major Raw Material Providers
  • Table 5: Global Osteoarthritis Market, Major Resource Providers
  • Table 6: Global Osteoarthritis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Osteoarthritis Market, Major Distributors And Channel Partners
  • Table 8: Global Osteoarthritis Market, Key Technologies & Future Trends
  • Table 9: Global Osteoarthritis Market, Major Trends
  • Table 10: Global Osteoarthritis Market, Major End Users
  • Table 11: Global Osteoarthritis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Osteoarthritis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Osteoarthritis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Osteoarthritis Market - TAM, US$ Billion, 2025
  • Table 15: Global Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Osteoarthritis Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Osteoarthritis Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Osteoarthritis Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Osteoarthritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Osteoarthritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Osteoarthritis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Osteoarthritis Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: Johnson & Johnson Financial Performance
  • Table 101: Merck Sharp & Dohme Corp. Financial Performance
  • Table 102: AbbVie Inc. Financial Performance
  • Table 103: Bayer AG Financial Performance
  • Table 104: Global Osteoarthritis Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Osteoarthritis Market, Competitive Dashboard
  • Table 106: Global Osteoarthritis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Osteoarthritis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Osteoarthritis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 109: Global, Osteoarthritis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Osteoarthritis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Osteoarthritis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Osteoarthritis Market, Supply Chain Analysis
  • Figure 4: Global Osteoarthritis Market, Major Raw Material Providers
  • Figure 5: Global Osteoarthritis Market, Major Resource Providers
  • Figure 6: Global Osteoarthritis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Osteoarthritis Market, Major Distributors And Channel Partners
  • Figure 8: Global Osteoarthritis Market, Key Technologies & Future Trends
  • Figure 9: Global Osteoarthritis Market, Major Trends
  • Figure 10: Global Osteoarthritis Market, Major End Users
  • Figure 11: Global Osteoarthritis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Osteoarthritis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Osteoarthritis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Osteoarthritis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Osteoarthritis Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Osteoarthritis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Osteoarthritis Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Osteoarthritis Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Osteoarthritis Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Osteoarthritis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Osteoarthritis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Osteoarthritis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Osteoarthritis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Osteoarthritis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Osteoarthritis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Osteoarthritis Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: Johnson & Johnson Financial Performance
  • Figure 101: Merck Sharp & Dohme Corp. Financial Performance
  • Figure 102: AbbVie Inc. Financial Performance
  • Figure 103: Bayer AG Financial Performance
  • Figure 104: Global Osteoarthritis Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Osteoarthritis Market, Competitive Dashboard
  • Figure 106: Global Osteoarthritis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Osteoarthritis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Osteoarthritis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 109: Global, Osteoarthritis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Osteoarthritis Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Therapy), By Diagnosis (Imaging, Joint Fluid Analysis), By Route Of Administration (Parenteral Route, Topical Route, Oral Route), By...

Axial Spondyloarthritis (axSpA) Market Report 2026 - Global Outlook – By Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA)), By Commercialized Therapies (Anti-Tumor Necrosis Factor Th...

Gouty Arthritis Market Report 2026 - Global Outlook – By Type (Acute Gouty Arthritis, Chronic Gouty Arthritis), By Treatment (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxida...

Osteoporosis Drugs Market Report 2026 - Global Outlook – By Type (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors ), By Administration (Oral, Injectable), By Distribution Channel (...

Knee Bursitis Market Report 2026 - Global Outlook – By Diagnosis (Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support), By Treatment (Medication, Therapy, Surgery, Oth...

Chondroplasty Market Report 2026 - Global Outlook – By Type (Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Patellar Chondroplasty, Tissue Removal, Other Types), By Anatomy (Knee, Shoulder, Hip, Other Ana...

Bone And Joint Health Supplements Market Report 2026 - Global Outlook – By Type (Vitamin D, Vitamin K, Calcium, Collagen, Omega-3 Fatty acids, Glucosamine-Chondroitin, Other Type), By Form Type (Tablets, Capsules, Liquid...

Emollients Market Report 2026 - Global Outlook – By Type (Esters, Fatty Alcohols, Fatty Acids, Ethers, Silicones, Other Types), By Form (Solid, Liquid), By Application (Skin Care, Hair Care, Other Applications), By End U...

Frequently Asked Questions

The Osteoarthritis market was valued at $7.49 billion in 2025, increased to $8.16 billion in 2026, and is projected to reach $11.92 billion by 2030. request a sample here

The global Osteoarthritis market is expected to grow at a CAGR of 9.9% from 2026 to 2035 to reach $11.92 billion by 2035. request a sample here

Some Key Players in the Osteoarthritis market Include, Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc. . request a sample here

Major trend in this market includes: Partnership Approaches And Advanced Treatments Transform The Osteoarthritis Market. For further insights on this market. request a sample here

North America was the largest region in the osteoarthritis market in 2025. The regions covered in the osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Osteoarthritis Market Report 2026 market are Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc. request a sample here.

North America was the largest region in the osteoarthritis market in 2025. The regions covered in the osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us